Pathogen-reduced platelets for the prevention of bleeding (protocol)
This is the protocol for a review and there is no abstract. The objectives are as follows:To determine the effectiveness and safety of pathogen-reduced platelets for the prevention of bleeding in all patients requiring platelet transfusion(s).
Hlavní autoři: | Butler, C, Doree, C, Estcourt, L, Stanworth, S, Brunskill, S, Hopewell, S, Murphy, M |
---|---|
Médium: | Journal article |
Vydáno: |
2011
|
Podobné jednotky
-
Pathogen-reduced platelets for the prevention of bleeding.
Autor: Butler, C, a další
Vydáno: (2013) -
Pathogen-reduced platelets for the prevention of bleeding (Review)
Autor: Butler, C, a další
Vydáno: (2013) -
Pathogen-reduced platelets for the prevention of bleeding (Review)
Autor: Estcourt, L, a další
Vydáno: (2017) -
Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
Autor: Wardrop, D, a další
Vydáno: (2016) -
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Autor: Estcourt, L, a další
Vydáno: (2016)